Who has invested in Proteon Therapeutics?

Deerfield Management are named among the investors backing Proteon Therapeutics.

Proteon Therapeutics Funding: $185M Raised, Series A (2017)

Proteon Therapeutics funding overview

Proteon Therapeutics is based in Waltham, Massachusetts. Proteon Therapeutics has raised $185M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in June 2017. The round record for Proteon Therapeutics runs through 2017; nothing later has been disclosed. Investors on record include Deerfield Management.

Proteon Therapeutics at a glance

Total raised: $185M
Latest round: Series A
Latest round date: June 2017
Headquarters: Waltham, Massachusetts
Notable investors: Deerfield Management

Frequently asked about Proteon Therapeutics funding

How much has Proteon Therapeutics raised?: Proteon Therapeutics has raised $185M in total disclosed funding across the rounds on record.
Who has invested in Proteon Therapeutics?: Deerfield Management are named among the investors backing Proteon Therapeutics.
What was the latest Proteon Therapeutics funding round?: The most recent disclosed round is a Series A, announced in June 2017.
Where is Proteon Therapeutics based?: Proteon Therapeutics is based in Waltham, Massachusetts.
When did Proteon Therapeutics last raise?: The last disclosed Proteon Therapeutics round closed in June 2017 at Series A.

We update the Proteon Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Waltham and their backers are listed below.

Proteon Therapeutics Funding: $185M Raised, Series A (2017)

Proteon Therapeutics funding overview

Proteon Therapeutics at a glance

Frequently asked about Proteon Therapeutics funding

Companies related to Proteon Therapeutics (36)

Browse related funding lists (4)